BBOT
Price
$11.51
Change
+$0.44 (+3.97%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
885.47M
83 days until earnings call
Intraday BUY SELL Signals
VKTX
Price
$38.56
Change
+$3.15 (+8.90%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
4B
69 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BBOT vs VKTX

Header iconBBOT vs VKTX Comparison
Open Charts BBOT vs VKTXBanner chart's image
BridgeBio Oncology Therapeutics
Price$11.51
Change+$0.44 (+3.97%)
Volume$3.06K
Capitalization885.47M
Viking Therapeutics
Price$38.56
Change+$3.15 (+8.90%)
Volume$84.01K
Capitalization4B
BBOT vs VKTX Comparison Chart in %
View a ticker or compare two or three
VS
BBOT vs. VKTX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBOT is a Buy and VKTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (BBOT: $11.07 vs. VKTX: $35.41)
Brand notoriety: BBOT and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBOT: 147% vs. VKTX: 64%
Market capitalization -- BBOT: $885.47M vs. VKTX: $4B
BBOT [@Biotechnology] is valued at $885.47M. VKTX’s [@Biotechnology] market capitalization is $4B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBOT’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • BBOT’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, BBOT is a better buy in the long-term than VKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBOT’s TA Score shows that 4 TA indicator(s) are bullish while VKTX’s TA Score has 4 bullish TA indicator(s).

  • BBOT’s TA Score: 4 bullish, 4 bearish.
  • VKTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BBOT is a better buy in the short-term than VKTX.

Price Growth

BBOT (@Biotechnology) experienced а -9.11% price change this week, while VKTX (@Biotechnology) price change was -2.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.21%. For the same industry, the average monthly price growth was +5.86%, and the average quarterly price growth was +56.03%.

Reported Earning Dates

BBOT is expected to report earnings on Feb 25, 2026.

VKTX is expected to report earnings on Feb 11, 2026.

Industries' Descriptions

@Biotechnology (+1.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($4B) has a higher market cap than BBOT($885M). BBOT YTD gains are higher at: 5.429 vs. VKTX (-12.003). BBOT has higher annual earnings (EBITDA): -94.43M vs. VKTX (-212.42M). VKTX has more cash in the bank: 808M vs. BBOT (131M). VKTX has less debt than BBOT: VKTX (878K) vs BBOT (2.83M). BBOT (0) and VKTX (0) have equivalent revenues.
BBOTVKTXBBOT / VKTX
Capitalization885M4B22%
EBITDA-94.43M-212.42M44%
Gain YTD5.429-12.003-45%
P/E RatioN/AN/A-
Revenue00-
Total Cash131M808M16%
Total Debt2.83M878K323%
FUNDAMENTALS RATINGS
VKTX: Fundamental Ratings
VKTX
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
72
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBOTVKTX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
11%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
19%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
18%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
22%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 18 days ago
51%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
40%
Bearish Trend 14 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
17%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
35%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BBOT
Daily Signal:
Gain/Loss:
VKTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SZCIX52.980.68
+1.30%
DWS Small Cap Core Inst
TAREX26.730.24
+0.91%
Third Avenue Real Estate Value Instl
RSDQX28.610.13
+0.46%
Invesco Rising Dividends R5
NEFFX78.920.31
+0.39%
American Funds New Economy F2
CAABX27.65-0.02
-0.07%
ClearBridge Sustainability Leaders C

BBOT and

Correlation & Price change

A.I.dvisor tells us that BBOT and VKTX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BBOT and VKTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBOT
1D Price
Change %
BBOT100%
-2.47%
VKTX - BBOT
27%
Poorly correlated
+4.52%
COCP - BBOT
25%
Poorly correlated
+2.97%
PRTC - BBOT
22%
Poorly correlated
N/A
VTGN - BBOT
21%
Poorly correlated
+3.61%
SNGX - BBOT
21%
Poorly correlated
-1.90%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with NEVPF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+4.52%
NEVPF - VKTX
45%
Loosely correlated
N/A
SYRE - VKTX
45%
Loosely correlated
+13.38%
GPCR - VKTX
43%
Loosely correlated
-1.56%
IMTX - VKTX
41%
Loosely correlated
+4.55%
RGNX - VKTX
41%
Loosely correlated
+5.49%
More